| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0001795> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0007667> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0010456> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0028296> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0028829> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0038954> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0086595> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0242793> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0919747> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C0948245> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C1698754> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/33010257_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Internal Medicine Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Rheumatology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Immunology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Pneumology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Intensive Care Unit, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Emergency Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Hematology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Hospital Pharmacy Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Microbiology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Immunology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain; Centro de Investigación Biomédica en Red - Enfermedades Cardiovasculares (CIBER CV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.\', \'Rheumatology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. Electronic address: isidoro.ga@ser.es.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Aguilar_Juan_Mariano> <https://research.tib.eu/covid-19/entity/Albert_Patricia> <https://research.tib.eu/covid-19/entity/Alcaraz-Serna_Ana> <https://research.tib.eu/covid-19/entity/Alfranca_Arantzazu> <https://research.tib.eu/covid-19/entity/Alonso_Tamara> <https://research.tib.eu/covid-19/entity/Ancochea_Julio> <https://research.tib.eu/covid-19/entity/Canabal_Alfonso> <https://research.tib.eu/covid-19/entity/Carde%C3%B1oso_Laura> <https://research.tib.eu/covid-19/entity/Del_Arco_Carmen> <https://research.tib.eu/covid-19/entity/Del_Campo_Guerola_Luciana> <https://research.tib.eu/covid-19/entity/Esparcia_Laura> <https://research.tib.eu/covid-19/entity/Fern%C3%A1ndez-D%C3%ADaz_Carlos> <https://research.tib.eu/covid-19/entity/Fraile_Torres_Arturo> <https://research.tib.eu/covid-19/entity/Gabrie_Ligia> <https://research.tib.eu/covid-19/entity/Galv%C3%A1n-Rom%C3%A1n_Jos%C3%A9_Mar%C3%ADa> <https://research.tib.eu/covid-19/entity/Garc%C3%ADa-Fraile_Lucio> <https://research.tib.eu/covid-19/entity/Garc%C3%ADa-Vicu%C3%B1a_Rosario> <https://research.tib.eu/covid-19/entity/Gonz%C3%A1lez-%C3%81lvaro_Isidoro> <https://research.tib.eu/covid-19/entity/L%C3%B3pez-Sanz_Celia> <https://research.tib.eu/covid-19/entity/Landete_Pedro> <https://research.tib.eu/covid-19/entity/Marcos-Jim%C3%A9nez_Ana> <https://research.tib.eu/covid-19/entity/Mart%C3%ADn-Gayo_Enrique> <https://research.tib.eu/covid-19/entity/Mart%C3%ADnez-Fleta_Pedro> <https://research.tib.eu/covid-19/entity/Mateu-Albero_Tamara> <https://research.tib.eu/covid-19/entity/Mu%C3%B1oz-Calleja_Cecilia> <https://research.tib.eu/covid-19/entity/Ram%C3%ADrez_Esther> <https://research.tib.eu/covid-19/entity/Rodr%C3%ADguez-Cortes_Pablo> <https://research.tib.eu/covid-19/entity/Rodr%C3%ADguez-Garc%C3%ADa_Sebasti%C3%A1n_C> <https://research.tib.eu/covid-19/entity/Rodr%C3%ADguez-Serrano_Diego_A> <https://research.tib.eu/covid-19/entity/Roy-Vallejo_Emilia> <https://research.tib.eu/covid-19/entity/S%C3%A1nchez-Alonso_Santiago> <https://research.tib.eu/covid-19/entity/S%C3%A1nchez-Cerrillo_Ildefonso> <https://research.tib.eu/covid-19/entity/S%C3%A1nchez-Madrid_Francisco> <https://research.tib.eu/covid-19/entity/Serra_Jos%C3%A9_Mar%C3%ADa> <https://research.tib.eu/covid-19/entity/Soriano_Joan_B> <https://research.tib.eu/covid-19/entity/Su%C3%A1rez-Fern%C3%A1ndez_Carmen> <https://research.tib.eu/covid-19/entity/Zurita_Cruz_Nelly_Daniela> <https://research.tib.eu/covid-19/entity/de_Los_Santos_Ignacio> <https://research.tib.eu/covid-19/entity/de_la_C%C3%A1mara_Rafael>
?:doi	S0091-6749(20)31329-410.1016/j.jaci.2020.09.018
?:doi	<https://research.tib.eu/covid-19/entity/S0091-6749%2820%2931329-410.1016/j.jaci.2020.09.018>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Observational_Study> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	The Journal of allergy and clinical immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33010257>
?:pmid	<https://research.tib.eu/covid-19/entity/33010257>
?:pmid	33010257
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0021760_INHIBITS_C0597357> <https://research.tib.eu/covid-19/entity/C0030705_LOCATION_OF_C0021760> <https://research.tib.eu/covid-19/entity/C0079189_ASSOCIATED_WITH_C0035222> <https://research.tib.eu/covid-19/entity/C0597357_ADMINISTERED_TO_C0870668> <https://research.tib.eu/covid-19/entity/C0948245_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C1519255_PROCESS_OF_C0030705>
?:title	IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Internal Medicine Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Rheumatology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Immunology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Pneumology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Intensive Care Unit, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Emergency Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Hematology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Hospital Pharmacy Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Microbiology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.\', \'Immunology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain; Centro de Investigación Biomédica en Red - Enfermedades Cardiovasculares (CIBER CV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.\', \'Rheumatology Service, Hospital Universitario de la Princesa, Universidad Autónoma Madrid, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. Electronic address: isidoro.ga@ser.es.\']

?:citedBy